Skip to content
10-Q

Quarterly Report

AMYLIN PHARMACEUTICALS INC

0001193125-11-286369

← back to feed
Filed
Oct 28, 2011 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 21, 2011 146.28M sh
Capex Q3 2011 · Sep 30, 2011 $41.31M
Capex Q3 2011 · Sep 30, 2010 $75.56M
Operating Cash Flow Q3 2011 · Sep 30, 2011 $68.96M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$43.59M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $107.4M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $164.52M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $157.63M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $120.83M
Stockholders Equity Q3 2011 · Sep 30, 2011 $312.48M
Stockholders Equity Q3 2011 · Dec 31, 2010 $343.48M
Current Liabilities Q3 2011 · Sep 30, 2011 $242.29M
Current Liabilities Q3 2011 · Dec 31, 2010 $401.6M
Current Assets Q3 2011 · Sep 30, 2011 $659M
Current Assets Q3 2011 · Dec 31, 2010 $676.4M
Total Assets Q3 2011 · Sep 30, 2011 $1.52B
Total Assets Q3 2011 · Dec 31, 2010 $1.53B
Sga Expense Q3 2011 · Sep 30, 2011 $63.06M
Sga Expense Q3 2011 · Sep 30, 2011 $192.9M
Sga Expense restated Q3 2011 · Sep 30, 2010 $70.02M
Sga Expense restated Q3 2011 · Sep 30, 2010 $214.33M
Rd Expense Q3 2011 · Sep 30, 2011 $46.56M
Rd Expense Q3 2011 · Sep 30, 2011 $133.54M
Rd Expense restated Q3 2011 · Sep 30, 2010 $51.16M
Rd Expense restated Q3 2011 · Sep 30, 2010 $145.57M
Net Income Q3 2011 · Sep 30, 2011 −$13.2M
Net Income Q3 2011 · Sep 30, 2011 −$81.93M
Net Income Q3 2011 · Sep 30, 2010 −$50.73M
Net Income Q3 2011 · Sep 30, 2010 −$133.13M
Operating Income Q3 2011 · Sep 30, 2011 −$7.78M
Operating Income Q3 2011 · Sep 30, 2011 −$61.71M
Operating Income Q3 2011 · Sep 30, 2010 −$45.03M
Operating Income Q3 2011 · Sep 30, 2010 −$116.43M
Cost Of Revenue Q3 2011 · Sep 30, 2011 $11.67M
Cost Of Revenue Q3 2011 · Sep 30, 2011 $36.06M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $12.68M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $47.64M
Revenue Q3 2011 · Sep 30, 2011 $174.96M
Revenue Q3 2011 · Sep 30, 2011 $485.74M
Revenue Q3 2011 · Sep 30, 2010 $156.1M
Revenue Q3 2011 · Sep 30, 2010 $494.62M
Stock Issued Q3 2011 · Mar 31, 2011 1M sh
Stock Issued Q3 2011 · Feb 28, 2011 200K sh